Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents.
Muhammad Salman FaisalWalter HanelTimothy VoorheesRui LiYing HuangAbdullah Mohammad KhanDavid BondYazeed SawalhaJohn ReneauLapo AlinariRobert BaiocchiBeth ChristianKami MaddocksYvonne EfeberaSam PenzaAyman SaadJonathan BrammerMarcos DeLimaSamantha JaglowskiNarendranath EpperlaPublished in: Cancer medicine (2023)
Despite the advent of novel therapies, allo-HCT remains an important therapeutic option for patients with R/R HL.